SEC Filings

MEDTRONIC PLC filed this Form DEFR14A on 10/11/2017
Entire Document

Corporate Governance Highlights


Strong Lead Independent Director

See page 19


Annual Board and Committee
Evaluation Processes

See page 20


Robust Risk Management Program

See page 19


Stock Ownership Guidelines for
Named Executive Officers and Directors

See pages 20 and 47


Annual Board of Director Elections and
Majority Voting for Directors

See page 12


Regular Executive Sessions of
Independent Directors

See page 19


Realigned Board Committees and
Chair Assignments

See page 21


Sustainability and Citizenship Highlights

See page 10

  Proxy Access

High Ethical Standards Established in Written Policies and Actions (Includes Codes of Conduct, U.S. Patient Privacy Principles, Political Contribution Policy, and Policies Regarding Environmental, Health and Safety and the Use of Animals)

See page 27 and our investor relations website


2017 Board Composition



Shareholder Outreach on Governance


We recognize the value of shareholder engagement and take a proactive approach to shareholder outreach on governance matters. We continuously engage with our shareholders, including investment and governance specialists, to seek input on governance, executive compensation, strategic issues and to address their questions and concerns. We bring feedback from our shareholders to our Board; such feedback is instrumental to the Board’s decision-making process.





MEDTRONIC PLC   2017 Proxy Statement    7